We are live on ! Find out more

13 hedge funds and large institutions have $2.26M invested in BiomX in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

30% more funds holding

Funds holding: 1013 (+3)

0.01% more ownership

Funds ownership: 0.09%0.09% (+0.01%)

14% less capital invested

Capital invested by funds: $2.62M → $2.26M (-$359K)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
13
Holders Change
+3
Holders Change %
+30%
% of All Funds
0.19%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
4
Increased
1
Reduced
3
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
O
1
OrbiMed
New York
$1.26M -$11.9K -189 -0.8%
JJ
2
Johnson & Johnson
New Jersey
$597K
8GI
3
8VC GP I
Texas
$304K +$360K +5,717 New
Renaissance Technologies
4
Renaissance Technologies
New York
$31K -$11.4K -181 -24%
MI
5
MMCAP International
Cayman Islands
$26.3K -$138K -2,187 -81%
BCM
6
Bridgeway Capital Management
Texas
$13.9K
Citadel Advisors
7
Citadel Advisors
Florida
$9.4K +$11.1K +177 New
Walleye Capital
8
Walleye Capital
New York
$5.9K
XT
9
XTX Topco
Cayman Islands
$4.07K +$4.78K +76 New
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$3.05K +$3.59K +57 New
Walleye Trading
11
Walleye Trading
New York
$2.92K
PNC Financial Services Group
12
PNC Financial Services Group
Pennsylvania
$1.12K
UBS Group
13
UBS Group
Switzerland
$560 +$629 +10 +1,000%
Millennium Management
14
Millennium Management
New York
-$8.22K -123 Closed

PHGE Hedge Fund Activity: Q4 2023 in Review

13 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in BiomX (PHGE) for Q4 2023, worth a combined $2.26M — down 14% from $2.62M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new PHGE positions and 1 closed out — a net gain of 3 holders — while 1 added to existing stakes and 3 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $11.1K. The largest seller was MMCAP International, cutting an estimated $138K.

  • 13 institutional investors held BiomX (PHGE) as of Q4 2023, up from 10 in Q3 2023.
  • Funds reported $2.26M of BiomX stock for Q4 2023, down 14% quarter-over-quarter.
  • 4 funds opened new BiomX positions in Q4 2023 and 1 closed out, a net change of +3 holders.
  • The largest BiomX buyer in Q4 2023 was Citadel Advisors, an estimated $11.1K added.
  • The largest BiomX seller in Q4 2023 was MMCAP International, an estimated $138K sold.

Based on aggregated 13F filings for Q4 2023.